期刊文献+

微量白蛋白尿与急性缺血性卒中患者短期转归的相关性

Correlation between microalbuminuria and short-term outcome in patients with acute ischemic stroke
原文传递
导出
摘要 目的探讨尿微量白蛋白(microalbuminuria, MAU)与急性缺血性卒中患者短期转归的关系。方法前瞻性纳入住院治疗的连续急性缺血性卒中患者。入院后次日晨起留取首次尿标本测定尿白蛋白/肌酐比率(urine albumin/ creatinine ratio, UACR),UACR 30~300 mg/g定义为MAU阳性。入院时采用美国国立卫生研究院卒中量表(National Institute of Health Stroke Scale, NIHSS)评价卒中严重程度,出院时采用改良Rankin量表(modified Rankin Scale, mRS)评价功能转归,0~2分定义为转归良好。结果共纳入244例急性缺血性卒中患者,其中53例(21.72%)MAU阳性,67例(27.50%)转归不良。单变量分析显示,MAU阳性组患者年龄、基线NIHSS评分、收缩压、空腹血糖、球蛋白、D-二聚体、白细胞计数、中性粒细胞以及缺血性心脏病构成比显著高于MAU阴性组(P均〈0.05)。转归不良组基线NIHSS评分、空腹血糖、纤维蛋白原、间接胆红素、直接胆红素、C反应蛋白、D-二聚体、白细胞计数、中性粒细胞以及MAU阳性患者构成比显著高于转归良好组(P均〈0.05)。多变量logistic回归分析显示,MAU[优势比(odds ratio, OR)1.520,95%可信区间(confidence interval, CI)1.151~1.794;P=0.031]、基线NIHSS评分(OR 1.570,95% CI 1.357~1.808;P〈0.001)是急性缺血性卒中患者短期转归不良的独立危险因素。结论急性缺血性卒中患者的MAU发生率较高,MAU阳性可作为急性缺血性卒中患者短期转归不良的独立预测指标之一。 ObjectiveTo investigate the relationship between microalbuminuria (MAU) and short-term outcome in patients with acute ischemic stroke.MethodsThe consecutive patients with acute ischemic stroke admitted to hospital were enrolled prospectively. The first urine specimen was taken on the following morning after admission for detecting urine albumin/creatinine ratio (UACR). UACR 30-300 mg/g was defined as MAU positive. Stroke severity was evaluated with the National Institutes of Health Stroke Scale (NIHSS) at admission and the modified Rankin Scale (mRS) was used to evaluate functional outcome at discharge, and good outcome was defined as mRS score of 0 to 2.ResultsA total of 244 patients with acute ischemic stroke were enrolled, including MAU positive in 53 patients (27.12%), and poor outcome in 67 patients (27.50%). Univariate analysis showed that age, baseline NIHSS score, systolic blood pressure, fasting blood glucose, globulin, D-dimer, white blood cell count, neutrophils, and the proportions of ischemic heart disease in patients of the MAU positive group were significantly higher than those of the MAU negative group (all P〈0.05). Multivariate logistic regression analysis showed that MAU (odds ratio [OR] 1.520, 95% confidence interval [CI] 1.151-1.794; P=0.031), baseline NIHSS score (OR 1.570, 95% CI 1.357-1.808; P〈0.001) were the independent risk factors for short-term poor outcome in patients with acute ischemic stroke.ConclusionsThe incidence of MAU is high in patients with acute ischemic stroke. MAU positive can be used as one of the independent predictors of short-term poor outcome in patients with acute ischemic stroke.
作者 李方睿 暴秀颖 连宇 景明 金小萌 包成月 Li Fangrui Bao Xiuying Lian Yu Jing Min Jin Xiaomeng Bao Chengyue(Department of Neurology, People's Hospital of Hinggan League, Ulanhot 137400, China)
出处 《国际脑血管病杂志》 2017年第6期516-520,共5页 International Journal of Cerebrovascular Diseases
关键词 卒中 脑缺血 白蛋白尿 预后 生物标志物 危险因素 Stroke Brain Ischemia Albuminuria Prognosis Biomarkers Risk Factors
  • 相关文献

参考文献1

二级参考文献19

  • 1中华神经科学会.各类脑血管疾病诊断要点.中华神经科杂志,1955,28:379.
  • 2KDOQI. KDOQI Oinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis, 2007, 49(2 Suppl2): S12-S154.
  • 3中国医师协会高血压专业委员会,中国医师协会内分泌代谢科医师分会,《中华高血压杂志》编辑委员会.高血压与糖尿病患者微量白蛋白尿的筛查干预中国专家共识.中华高血压杂志,2012,20:423-428.
  • 4Olsen MH, Sehestedt T, Lyngbaek S, et al. Urine albumin/creatinine ratio, high sensitivity C-reactive protein and N-terminal pro brain natriuretic peptide-three new cardiovascular risk markers-do they improve risk prediction and influence treatment? Curr Vasc Pharmacol, 2010, 8: 134-139.
  • 5Adams HP Jr, Bendixen BH, Kappelle U, et al. Classification of subtype of acute ischemic stroke. Defmitions for use in a muhicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993,24: 35-41.
  • 6Muchada M, Rubiera M, Rodriguez-Luna D, et al. Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke. Stroke, 2014, 45: 1059-1063.
  • 7Vaur L, Gueret P, Lievre M, et al. DIABHYCAR Study Group (type 2 DIABetes, Hypertension, CARdiovascular Events and Ramipril) study. Development of congestive heart failure in type 2 diabetic patients with microalburninuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study. Diabetes Care, 2003, 26: 855 -860.
  • 8Urnemura T, Kawamura T, Sakakibara T, et al. Microalburninuria is independently associated with deep or infratentorial brain microbleeds in hypertensive adults. Am J Hypertens, 2012, 25: 430-436.
  • 9Nidhinandana S, Chaisinanunkul N. The association between risk factors for ischemic stroke and microalbuminuria. J Med Assoc Thai, 2010, 93(SuppI6): S55-S59.
  • 10Diercks GF, van Boven AJ, Hil1ege JL, et al. The importance of microalbuminuria as a cardiovascular risk indicator: A review. Can J Cardiel, 2002, 18: 525-535.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部